M de Benedetti - JoVE Visualize

Showing results (1-10 of 12) with videos related to

Pageof 2

Sort By:

The International Journal of Biological Markers|April 14, 2000

DNA chips: the future of biomarkersV M De Benedetti, N Biglia, P Sismondi, et al.

Carcinogenesis|January 1, 1996

p53 mutations in hepatocellular carcinoma related to oral contraceptive useV M De Benedetti, J A Welsh, M C Yu, et al.

Giornale Italiano Di Medicina Del Lavoro|July 1, 1988

[Various air pollutants in Torino]I Pavan, P Natale, M De Benedetti, et al.

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 1, 1995

p53 is not mutated in hepatocellular carcinomas from Alaska NativesV M De Benedetti, J A Welsh, G E Trivers, et al.

Human Mutation|February 5, 2000

Characterization of ten novel and 13 recurring BRCA1 and BRCA2 germline mutations in Italian breast and/or ovarian carcinoma patients. Mutations in brief no. 178. OnlineV M De Benedetti, P Radice, B Pasini, et al.

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 1, 1996

p53 mutations in lung cancer following radiation therapy for Hodgkin's diseaseV M De Benedetti, L B Travis, J A Welsh, et al.

International Journal of Cancer|November 3, 1995

Lung carcinoma and malignant mesothelioma in patients exposed to Thorotrast: incidence, histology and p53 statusM Andersson, H Wallin, M Jönsson, et al.

Oncogene|September 19, 1996

Screening for mutations in exon 11 of the BRCA1 gene in 70 Italian breast and ovarian cancer patients by protein truncation testV M De Benedetti, P Radice, P Mondini, et al.

Carcinogenesis|May 1, 1995

Gender comparisons in human lung cancer: analysis of p53 mutations, anti-p53 serum antibodies and C-erbB-2 expressionD G Guinee, W D Travis, G E Trivers, et al.

Cancer Research|November 1, 1996

Circulating anti-p53 antibodies in esophageal cancer patients are found predominantly in individuals with p53 core domain mutations in their tumorsM C von Brevern, M C Hollstein, H M Cawley, et al.

Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:

Pageof 2

The International Journal of Biological Markers|April 14, 2000

DNA chips: the future of biomarkersV M De Benedetti, N Biglia, P Sismondi, et al.

Carcinogenesis|January 1, 1996

p53 mutations in hepatocellular carcinoma related to oral contraceptive useV M De Benedetti, J A Welsh, M C Yu, et al.

Giornale Italiano Di Medicina Del Lavoro|July 1, 1988

[Various air pollutants in Torino]I Pavan, P Natale, M De Benedetti, et al.

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 1, 1995

p53 is not mutated in hepatocellular carcinomas from Alaska NativesV M De Benedetti, J A Welsh, G E Trivers, et al.

Human Mutation|February 5, 2000

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 1, 1996

p53 mutations in lung cancer following radiation therapy for Hodgkin's diseaseV M De Benedetti, L B Travis, J A Welsh, et al.

International Journal of Cancer|November 3, 1995

Lung carcinoma and malignant mesothelioma in patients exposed to Thorotrast: incidence, histology and p53 statusM Andersson, H Wallin, M Jönsson, et al.

Oncogene|September 19, 1996

Screening for mutations in exon 11 of the BRCA1 gene in 70 Italian breast and ovarian cancer patients by protein truncation testV M De Benedetti, P Radice, P Mondini, et al.

Carcinogenesis|May 1, 1995

Gender comparisons in human lung cancer: analysis of p53 mutations, anti-p53 serum antibodies and C-erbB-2 expressionD G Guinee, W D Travis, G E Trivers, et al.

Cancer Research|November 1, 1996

Circulating anti-p53 antibodies in esophageal cancer patients are found predominantly in individuals with p53 core domain mutations in their tumorsM C von Brevern, M C Hollstein, H M Cawley, et al.

Pageof 2